Your browser doesn't support javascript.
loading
Pharmacovigilance in China: Evolution and future challenges.
Song, Haibo; Pei, Xiaojing; Liu, Zuoxiang; Shen, Chuanyong; Sun, Jun; Liu, Yuqin; Zhou, Lingyun; Sun, Feng; Xiao, Xiaohe.
Affiliation
  • Song H; National Center for ADR Monitoring, Beijing, China.
  • Pei X; NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance, Beijing, China.
  • Liu Z; Center for Drug Evaluation, NMPA, Beijing, China.
  • Shen C; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Sun J; National Center for ADR Monitoring, Beijing, China.
  • Liu Y; NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance, Beijing, China.
  • Zhou L; Center for Evaluation, Jiangsu Medical Products Administration, Nanjing, Jiangsu, China.
  • Sun F; Gansu Center for Drug and Medical Devices Adverse Reaction Monitoring, Lanzhou, Gansu, China.
  • Xiao X; Lingyun Zhou, Sanofi (China) Investment Co., Ltd, Shanghai Branch, Shanghai, China.
Br J Clin Pharmacol ; 89(2): 510-522, 2023 02.
Article in En | MEDLINE | ID: mdl-35165914
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Pharmacovigilance Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Br J Clin Pharmacol Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Pharmacovigilance Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Br J Clin Pharmacol Year: 2023 Type: Article Affiliation country: China